Deep Breaths: Updates from CHEST
by ReachMD
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇮🇳IN · Science#9710K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
5K to 15K🎙 Weekly cadence·41 episodes·Last published 3mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
10K to 30K🇮🇳100% - Active Followers
Loyal subscribers who consistently listen
3K to 9K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 13 epsHosts
Recent guests
Recent episodes
Diagnostic Challenges in Refractory Chronic Cough: From Burden to Solutions
May 7, 2026
16m 15s
What Type 2 Inflammation in COPD Means for Treatment Decision Making
Mar 6, 2026
15m 00s
Escalating COPD Care: From Flares to Long-Term Control
Feb 10, 2026
16m 30s
Recognizing Methamphetamine-Associated PAH: Strategies for Complex Care
Jan 2, 2026
16m 30s
Redefining Non-Small Cell Lung Cancer Care: Updates in Targeted and Perioperative Therapy
Dec 22, 2025
17m 15s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 5/7/26 | refractory chronic coughdiagnostic challenges+3 | Syed Shahzad Mustafa, MDAshley Wilk, DO, DipABLM | CHEST | — | chronic coughdiagnosis+5 | — | 16m 15s | ||
| 3/6/26 | COPDtype 2 inflammation+2 | Diego Maselli Md Fccp | the University of California San Franciscothe Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine+5 | San Antonio | exacerbation risktreatment response+3 | GSK | 15m 00s | ||
| 2/10/26 | COPDexacerbations+3 | Meilan K Han Md MsRavi Kalhan Md | the Asthma and COPD ProgramNorthwestern Medicine+5 | ChicagoAnn Arbor | chronic obstructive pulmonary diseaseeosinophil counts+1 | GSK | 16m 30s | ||
| 1/2/26 | methamphetaminepulmonary arterial hypertension+2 | Dana Kay DoSteven M Hollenberg Md | FCCPthe Division of Pulmonary and Critical Care+7 | San AntonioAtlanta | diagnosistreatment challenges+1 | Actelion Pharmaceuticals US, Inc. | 16m 30s | ||
| 12/22/25 | non-small cell lung cancertargeted therapy+3 | Gerard A Silvestri Md Ms Master FccpMariam Alexander Md Phd+1 | the Medical University of South Carolinathe Section of Thoracic Surgery+2 | — | EGFRROS1+2 | AstraZeneca | 17m 15s | ||
| 12/22/25 | non-small cell lung cancersurveillance strategies+5 | Adam H Fox Md MscAnurag Singh Md Phd | the Medical University of South Carolinathe Roswell Park Cancer Center+1 | New York | lung cancermedical updates+2 | AstraZeneca | 18m 15s | ||
| 5/23/25 | small cell lung cancertreatment advancements+2 | Adam H Fox Md MscMariam Alexander Md Phd+1 | the Medical University of South Carolinathe Roswell Park Cancer Center+1 | New York | prognosissurvival+2 | AstraZeneca | 17m 30s | ||
| 5/12/25 | IL-5severe asthma+2 | Monica Kraft Md FccpAnju T Peters Md Msci Faaaai | the Long School of MedicineUT Health+7 | San AntonioChicago+1 | asthma managementpatient selection+1 | GSK | 9m 45s | ||
| 4/15/25 | COPDchronic obstructive pulmonary disease+3 | Megan Conroy Md Ma Ed Fccp | CHEST’s COPD ToolkitCHEST+4 | — | diagnosistreatment+2 | Regeneron Pharmaceuticals, Inc. | 18m 15s | ||
| 11/19/24 | COPDpatient-centered care+1 | Susan Corbridge Phd Aprn Acnp-Bc Faanp Fccp FaanAntonio Anzueto Md | APRNACNP-BC+6 | MA | chronic obstructive pulmonary diseasehealthcare outcomes+1 | Regeneron Pharmaceuticals, Inc. | 10m 30s | ||
| 5/8/23 | Bronchiectasisairway dysfunction+2 | Christopher Lippincott Md Mph | the American College of CHEST PhysiciansThe Vicious Vortex: Key Mechanisms of Bronchiectasis | — | syndromeclinical mechanisms | Insmed Incorporated | 12m 30s | ||
| 5/8/23 | bronchiectasisairway clearance techniques+3 | Ashwin Basavaraj, MDAshwin Basavaraj | American College of CHEST Physicians | — | bronchiectasisairway clearance+3 | Insmed Incorporated | 12m 30s | ||
| 1/24/23 | COPD exacerbationspathophysiology+3 | Ron Balkissoon, MD, MSc, DIH, FRCPC | CHEST | — | COPDexacerbations+3 | GSK | 12m 00s |
Showing 13 of 13
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Deep Breaths: Updates from CHEST
Peaked at #97 in India, currently #97 in India.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| India | — | #97 | #97 | — |
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.